Report Detail
Global (United States, European Union and China) Antigout Drug Market Research Report 2019-2025
- RnM3627504 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Gout is a form of inflammatory arthritis characterized by recurrent attacks of a red, tender, hot, and swollen joint. Pain typically comes on rapidly in less than twelve hours.The joint at the base of the big toe is affected in about half of cases.It may also result in tophi, kidney stones, or urate nephropathy.
In 2019, the market size of Antigout Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antigout Drug.
This report studies the global market size of Antigout Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antigout Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Takeda
Aspen
heumann pharma
Teijin Pharma
Horizon Pharma
Novartis
WanBang
Jiangsu Hengrui Medicine
Rotamreddy
KPC Pharmaceuticals
Market Segment by Product Type
Febuxostat
Benzbromarone
Allopurinol
Colchicine
Market Segment by Application
Acute Gout
Chronic Gout
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antigout Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antigout Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antigout Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Antigout Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Febuxostat
- 1.3.3 Benzbromarone
- 1.3.4 Allopurinol
- 1.3.5 Colchicine
- 1.4 Market Segment by Application
- 1.4.1 Global Antigout Drug Market Share by Application (2019-2025)
- 1.4.2 Acute Gout
- 1.4.3 Chronic Gout
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Antigout Drug Market Size
- 2.1.1 Global Antigout Drug Revenue 2014-2025
- 2.1.2 Global Antigout Drug Sales 2014-2025
- 2.2 Antigout Drug Growth Rate by Regions
- 2.2.1 Global Antigout Drug Sales by Regions 2014-2019
- 2.2.2 Global Antigout Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Antigout Drug Sales by Manufacturers
- 3.1.1 Antigout Drug Sales by Manufacturers 2014-2019
- 3.1.2 Antigout Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Antigout Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Antigout Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antigout Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Antigout Drug Price by Manufacturers
- 3.4 Key Manufacturers Antigout Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Antigout Drug Market
- 3.6 Key Manufacturers Antigout Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Febuxostat Sales and Revenue (2014-2019)
- 4.1.2 Benzbromarone Sales and Revenue (2014-2019)
- 4.1.3 Allopurinol Sales and Revenue (2014-2019)
- 4.1.4 Colchicine Sales and Revenue (2014-2019)
- 4.2 Global Antigout Drug Sales Market Share by Type
- 4.3 Global Antigout Drug Revenue Market Share by Type
- 4.4 Antigout Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Antigout Drug Sales by Application
6 United States
- 6.1 United States Antigout Drug Breakdown Data by Company
- 6.2 United States Antigout Drug Breakdown Data by Type
- 6.3 United States Antigout Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Antigout Drug Breakdown Data by Company
- 7.2 European Union Antigout Drug Breakdown Data by Type
- 7.3 European Union Antigout Drug Breakdown Data by Application
8 China
- 8.1 China Antigout Drug Breakdown Data by Company
- 8.2 China Antigout Drug Breakdown Data by Type
- 8.3 China Antigout Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Antigout Drug Breakdown Data by Company
- 9.2 Rest of World Antigout Drug Breakdown Data by Type
- 9.3 Rest of World Antigout Drug Breakdown Data by Application
- 9.4 Rest of World Antigout Drug Breakdown Data by Countries
- 9.4.1 Rest of World Antigout Drug Sales by Countries
- 9.4.2 Rest of World Antigout Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Takeda
- 10.1.1 Takeda Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Antigout Drug
- 10.1.4 Antigout Drug Product Introduction
- 10.1.5 Takeda Recent Development
- 10.2 Aspen
- 10.2.1 Aspen Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Antigout Drug
- 10.2.4 Antigout Drug Product Introduction
- 10.2.5 Aspen Recent Development
- 10.3 heumann pharma
- 10.3.1 heumann pharma Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Antigout Drug
- 10.3.4 Antigout Drug Product Introduction
- 10.3.5 heumann pharma Recent Development
- 10.4 Teijin Pharma
- 10.4.1 Teijin Pharma Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Antigout Drug
- 10.4.4 Antigout Drug Product Introduction
- 10.4.5 Teijin Pharma Recent Development
- 10.5 Horizon Pharma
- 10.5.1 Horizon Pharma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Antigout Drug
- 10.5.4 Antigout Drug Product Introduction
- 10.5.5 Horizon Pharma Recent Development
- 10.6 Novartis
- 10.6.1 Novartis Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Antigout Drug
- 10.6.4 Antigout Drug Product Introduction
- 10.6.5 Novartis Recent Development
- 10.7 WanBang
- 10.7.1 WanBang Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Antigout Drug
- 10.7.4 Antigout Drug Product Introduction
- 10.7.5 WanBang Recent Development
- 10.8 Jiangsu Hengrui Medicine
- 10.8.1 Jiangsu Hengrui Medicine Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Antigout Drug
- 10.8.4 Antigout Drug Product Introduction
- 10.8.5 Jiangsu Hengrui Medicine Recent Development
- 10.9 Rotamreddy
- 10.9.1 Rotamreddy Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Antigout Drug
- 10.9.4 Antigout Drug Product Introduction
- 10.9.5 Rotamreddy Recent Development
- 10.10 KPC Pharmaceuticals
- 10.10.1 KPC Pharmaceuticals Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Antigout Drug
- 10.10.4 Antigout Drug Product Introduction
- 10.10.5 KPC Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Antigout Drug Sales Channels
- 11.2.2 Antigout Drug Distributors
- 11.3 Antigout Drug Customers
12 Market Forecast
- 12.1 Global Antigout Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Antigout Drug Sales Forecast by Type
- 12.3 Global Antigout Drug Sales Forecast by Application
- 12.4 Antigout Drug Forecast by Regions
- 12.4.1 Global Antigout Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antigout Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Antigout Drug. Industry analysis & Market Report on Antigout Drug is a syndicated market report, published as Global (United States, European Union and China) Antigout Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antigout Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
